GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
15.09
+0.30 (2.03%)
At close: Nov 20, 2024, 4:00 PM
15.45
+0.36 (2.39%)
Pre-market: Nov 21, 2024, 7:40 AM EST
GRAIL Employees
GRAIL had 1,360 employees as of December 31, 2023.
Employees
1,360
Change
n/a
Growth
n/a
Revenue / Employee
$86,521
Profits / Employee
-$1,556,960
Market Cap
507.04M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,360 | - | - |
Related Stocks
Company Name | Employees |
---|---|
MeiraGTx Holdings | 425 |
ProKidney | 163 |
Acelyrin | 135 |
Perspective Therapeutics | 119 |
Alumis | 109 |
Y-mAbs Therapeutics | 100 |
Theravance Biopharma | 99 |
Terns Pharmaceuticals | 66 |
GRAL News
- 1 day ago - GRAIL to Participate in Upcoming Investor Conferences - PRNewsWire
- 2 days ago - GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study - PRNewsWire
- 6 days ago - GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - GRAIL Reports Third Quarter 2024 Financial Results - PRNewsWire
- 16 days ago - GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PRNewsWire
- 22 days ago - GRAIL to Announce Third Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference - PRNewsWire
- 4 weeks ago - GRAIL Appoints Sarah Krevans to Board of Directors - PRNewsWire